Skip to content

AESTM

Journal of Experimental Stroke & Transitional Medicine

Primary menu

  • Home
  • About the Journal
  • Announcement
  • Author Guidelines
  • Mission, scope, and focus

Heart Attack And Stroke Are More Common After The Flu

Posted onNovember 2, 2017Leave a comment

The occurrence of heart attack and stroke is closely related to influenza, tetanus and meningococcal vaccine. Statistics show that heart attack and stroke often occur with modern humans, of course. However, now British scientists have found that their occurrence is Continue Reading

Tagsflu, heart attack, stroke

(Discussion) Novel experimental model for repeated forebrain ischemia-reperfusion

Posted onOctober 17, 2017October 17, 2017Leave a comment

Background and Purpose: The lack of reliable rodent model for repeated ischemia-reperfusion (I-R) hampers experimental research on stroke. Therefore, the objective of the present study was to develop a mouse model for repeated I-R cycles in a single animal on different Continue Reading

TagsCerebral blood flow, ischemia-reperfusion, preconditioning, stroke

One thing you have in anyone’s home that can save lives during a stroke

Posted onSeptember 27, 2017Leave a comment

A stroke may occur to anyone without warning. The main cause is stopping the blood flow to the brain. The result is that the brain cells are left without oxygen, and damaged parts of the brain cannot perform their functions. Continue Reading

Tagsalternative, first aid, needle, stroke

Marijuana – A Potential Remedy In Stroke And Translational Medicine?

Posted onSeptember 5, 2017September 6, 2017Leave a comment

Every year, almost a million people in the USA, 75% of whom are aged over 65, will suffer from a stroke, losing brain function due to a blockage in its blood supply. It has been estimated that around 15 million Continue Reading

(Discussion) Neuroprotection with Glycine-2-Methylproline-Glutamate (G-2MePE) after hypoxic-ischemic brain injury in adult rats

Posted onAugust 27, 2017September 6, 2017Leave a comment

Discussion In the present study G-2MePE treatment, by a single dose SC administration significantly reduced the extent of brain damage after HI injury. Attenuation of brain damage, neuronal loss and apoptosis were associated with reduced microglial reaction, TNF-α expression and Continue Reading

(Discussion) Chemokine receptor-like 2 is involved in ischemic brain injury

Posted onAugust 20, 2017September 6, 2017Leave a comment

Discussion In this study, we show that the expression of CCRL2, a chemokine receptor, is up-regulated in mouse brain slices under ischemic conditions. The deletion of CCRL2 not only reduced the ischemia-induced cell death in brain slices but attenuated tMCAO-induced Continue Reading

Long-term survival and serial assessment of stroke damage and recovery – practical and methodological considerations

Posted onAugust 10, 2017September 6, 2017Leave a comment

  Abstract Impairments caused by stroke remain the main cause for adult disability. Despite a vigorous research effort, only 1 thrombolytic treatment has been approved in acute stroke (<3h). The limitations of preclinical studies and how these can be overcome Continue Reading

Acute bioenergetic intervention or pharmacological preconditioning protects neuron against ischemic injury

Posted onAugust 1, 2017September 6, 2017Leave a comment

Abstract Although acute ischemic stroke has high mortality and morbidity rate but yet still has very limited treatment. In this study we have tested the concept of neuron protection by acute bioenergetic intervention or by pharmacological preconditioning with natural antioxidants. Continue Reading

Neuroprotection with Glycine-2-Methylproline-Glutamate (G-2MePE) after hypoxic-ischemic brain injury in adult rats

Posted onJuly 23, 2017September 6, 2017Leave a comment

Abstract Background and Purpose: Hypoxic-ischemic brain injury, due to reduced supply of oxygen to brain, is a major cause of death and disability. There is no exclusive treatment available so far. Glycine-2-Methylproline-Glutamate (G-2MePE, NNZ 2566), an analogue of Glycine-Proline-Glutamate reduces Continue Reading

Chemokine receptor-like 2 is involved in ischemic brain injury

Posted onJuly 15, 2017September 6, 2017Leave a comment

Abstract We examined the role of CCRL2 in ischemic brain injury using both in vitro and in vivo mouse stroke models. The expression of CCRL2 was enhanced at both the RNA and protein levels in cultured brain slices under ischemic Continue Reading

Post navigation

← Older posts

Recent Posts

  • Heart Attack And Stroke Are More Common After The Flu
  • (Discussion) Novel experimental model for repeated forebrain ischemia-reperfusion
  • One thing you have in anyone’s home that can save lives during a stroke
  • Marijuana – A Potential Remedy In Stroke And Translational Medicine?
  • (Discussion) Neuroprotection with Glycine-2-Methylproline-Glutamate (G-2MePE) after hypoxic-ischemic brain injury in adult rats

Submit Article






Copyright © 2018 AESTM. All Rights Reserved.
Clean Education by Catch Themes
Scroll Up